0001225208-21-009468.txt : 20210616
0001225208-21-009468.hdr.sgml : 20210616
20210616162230
ACCESSION NUMBER: 0001225208-21-009468
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210614
FILED AS OF DATE: 20210616
DATE AS OF CHANGE: 20210616
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Monson Jonathan
CENTRAL INDEX KEY: 0001779170
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11083
FILM NUMBER: 211021776
MAIL ADDRESS:
STREET 1: C/O BOSTON SCIENTIFIC CORPORATION
STREET 2: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP
CENTRAL INDEX KEY: 0000885725
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042695240
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
BUSINESS PHONE: 508-683-4000
MAIL ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
4
1
doc4.xml
X0306
4
2021-06-14
0000885725
BOSTON SCIENTIFIC CORP
BSX
0001779170
Monson Jonathan
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH
MA
01752-1234
1
VP, Global Controller and CAO
Common Stock
2021-06-14
4
M
0
5000.0000
13.0800
A
42062.0000
D
Common Stock
2021-06-14
4
S
0
5000.0000
42.9400
D
37062.0000
D
Common Stock
2021-06-15
4
M
0
7901.0000
12.8900
A
44963.0000
D
Common Stock
2021-06-15
4
S
0
7901.0000
42.7842
D
37062.0000
D
Stock Option (Right to Buy)
13.0800
2021-06-14
4
M
0
5000.0000
0.0000
D
2024-02-24
Common Stock
5000.0000
0.0000
D
Stock Option (Right to Buy)
12.8900
2021-06-15
4
M
0
7901.0000
0.0000
D
2024-12-01
Common Stock
7901.0000
10000.0000
D
The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $42.63 to $42.93, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Grant to the reporting person on February 24, 2014, of an option to purchase 15,000 shares of common stock.
Grant to the reporting person on December 1, 2014, of an option to purchase 17,901 shares of common stock.
/s/ Vance R. Brown, Attorney-in-fact
2021-06-16